Mass General: Clinicians Report Success With First Test of Drug in a Patient With Life-Threatening Blood Clotting Disorder
May 17, 2024
May 17, 2024
BOSTON, Massachusetts, May 17 (TNSres) -- Massachusetts General Hospital issued the following news release:
* * *
Key Takeaways
* Immune thrombotic thrombocytopenic purpura, a rare blood clotting disorder, results from an autoimmune attack against an enzyme called ADAMTS13
* A recombinant form of human ADAMTS13 approved for a different condition helped to save the life of a young mother with immune thrombotic thrombocytopenic purpura
* * *
Key Takeaways
* Immune thrombotic thrombocytopenic purpura, a rare blood clotting disorder, results from an autoimmune attack against an enzyme called ADAMTS13
* A recombinant form of human ADAMTS13 approved for a different condition helped to save the life of a young mother with immune thrombotic thrombocytopenic purpura